References
- Chirigos M. A., Stylos W. A. Immunomodulatory effect of various molecular-weight maleic anhydride divinyl ethers and other agents in vivo. Cancer Res. 1980; 40: 1967
- Stylos W. A., Chirigos M. A., Papademetriou V., Lauer L. The immunomodulatory effect of azimexone on normal or tumored mice: in vitro and in vivo studies. J. Immunopharmacol. 1980; 2(1)113
- Florentin I., Schulz J., Bruley-Rosset M., Kiger N., Martinez J., Mathé G. In vivo immunomodulating properties of two synthetic agents: azimexone and Tuftsin, Recent Results in Cancer Res. Cancer Chemo-and Immunopharmacol. 1980; 75: 153
- Luckenbach G. A., Cortez-Campeao D., Modolell M. L., Munder P. G. Immunomodulation by the new synthetic compound BM 12.531, 2-[2-cyanaziridinyl-(1)]-2-[2-carbamoylaziridinyl-(1)]-propane (azimexone). Exp. Path. 1981; 19(1)37
- Bicker U. Aziridine dyes: Preclinical and clinical studies. Augmenting Agents in Cancer Therapy, E. M. Hersh, et al. Raven Press, New York 1981; 523
- Olsson L., Ebbesen P., Hesse J. Influence of T-lymphocyte deprivation on the antileukemic effect of Bacillus Calmette-Guérin in vivo. CII 1980; 8: 231
- Reinherz E. L., Schlossman S. F. Regulation of the immune response - inducer and suppressor T-lymphocyte subsets in human beings. New Engl. J. Med. 1980; 303(7)370
- Keystone E. C., Gladman D. D., Buchanan R., Cane D., Poplonski L. Impaired antigenspecific suppressor cell activity in patients with rheumatoid arthritis. Arthritis and Rheumatism 1980; 23(11)1246
- Bach M.-A., Phan-Dinh-Tuy F., Tournier E., Chatenoud L., Bach J.-F. Deficit of suppressor T cells in active multiple sclerosis. Lancet 1980; 1221
- Chirigos M. A., Papademetriou V., Bartocci A., Read E. Immunological and tumor responses to various immunotherapeutic agents. Advances in Immunopharmacology, J. Hadden, et al. Perqamon Press, Oxford, New York, Toronto, Sydney, Paris, Frankfurt 1981; 217
- Bicker U., Zieqler A. E., Hebold G. Investigations in animals on the potentiation of resistance to infections by BM 12.531, 2–12-Cyan-aziridinyl-(1)]-2-[2-carbamoylaziridinyl-(1)]-propane, a new immunostimulant compound. J. Infect. Dis. 1979; 139: 389